Latest return on equity
Immunome Return on equity
Direct answer
Immunome's return on equity is -64.03%.
The verified market snapshot reports -64.03%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 16, 2026.
Get free Immunome email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -64.03%